Abstract:Objective: Recent evidence suggests that disturbances of sleep architecture are linked to Alzheimer's disease (AD) pathology. Here, we assessed the association between sleep architecture and regional amyloid and tau pathology employing a portable sleep-monitoring device in addition to PET imaging. Methods: 18 cognitively normal adults (CN; M(Age) = 64.06 (8.63), Sex (M/F) =6/12) and 18 patients with MCI/early AD (M(Age) = 67.33 (8.25), Sex (M/F) =9/9) were included from the 'Tau Propagation Over Time' (T-POT) study. All subjects underwent amyloid ([11C]-PiB) and tau ([18F]-AV1451) PET imaging. PET images were normalized to MNI-space and intensity standardized to the whole cerebellum ([11C]-PiB) or the inferior cerebellum ([18F]-AV1451). Sleep monitoring was performed at home using the portable 'Dreem' EEG-headband (Beacon Biosignal), which is a reliable and comfortable wireless alternative to the gold-standard polysomnography (PSG). Sleep recordings were performed within six months of the PET acquisitions. At least, one sufficient night had to be acquired, which was used to assess the sleep macrostructure for each individual. Total duration of sleep phases per minutes (i.e. REM, N1, N2, N3) and total sleep time were extracted. In a first step, a linear mixed model (LMM) was used to compare the groups in terms of duration of the different sleep stages across the nightly recordings. Given the results of this comparison, mean N1 and N3 duration were subsequently correlated with regional amyloid and tau pathology SUVRs of 34 cortical regions using Spearman's correlation. The reported results are based on one-tailed tests. All analyses were corrected for age. Results: Patients with MCI/AD showed reduced N3 duration (p = .007) compared to the CN group. A trend was observed indicating that patients with MCI/AD exhibited longer N1 durations (p = .094); however, this difference did not reach statistical significance. Shorter N3 duration was associated with higher regional amyloid load in the paracentral lobe and the posterior cingulate gyrus, whereas longer N1 duration was linked to higher amyloid pathology in several regions, including the medial temporal lobe, cingulate cortex and the occipital lobe. Moreover, associations were observed between longer N1 duration and greater tau burden in regions comprising the temporal lobe, cingulate cortex, and medial-frontal areas of the brain. Conclusion: Differences in sleep architecture between healthy controls and MCI/AD may arise from regionally-specific accumulation patterns of AD pathologies. Although it remains unknown whether disruptions in sleep architecture are a cause or a consequence, a complex relationship between AD-aggregation pathology in specific brain regions and the different phases of sleep appears to emerge.

1008 Daytime Sleepiness Is Associated with Increased Cerebrospinal Fluid Tau Proteins in Alzheimer’s Disease

Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity

Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning

Sleep Characteristics and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: the CABLE Study

Acute sleep loss decreases CSF‐to‐blood clearance of Alzheimer's disease biomarkers

Reduced Coupling Between Cerebrospinal Fluid Flow and Global Brain Activity is Linked to Alzheimer Disease–related Pathology

0744 Metrics of Sleep Apnea Severity and Sleep-Dependent Memory Consolidation

The coupling of global brain activity and cerebrospinal fluid inflow is correlated with Alzheimer's disease related pathology

The glymphatic system clears amyloid beta and tau from brain to plasma in humans

The Association of Subjective Sleep Characteristics and Plasma Biomarkers of Alzheimer's Disease Pathology in Older Cognitively Unimpaired Adults with Higher Amyloid-Β Burden.

Lateralized brunt of sleep deprivation on white matter injury in a rat model of Alzheimer's disease

1031 Association Between Objective Sleep Architecture and Biomarkers of Alzheimer's Disease

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course

Relationship Between P‐tau217 and Subjective Sleep Quality in MCI and Mild AD. A Preliminary Study

Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults.

The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans

Impaired sleep is associated with tau deposition on 18 F-flortaucipir PET and accelerated cognitive decline, accounting for medications that affect sleep

0224 Sleep Deprivation and Recovery Sleep Impact Serum Biomarkers of Alzheimer's Disease in Retired Adults

Sleep Fragmentation and Sleep-Wake Cycle Dysregulation Are Associated with Cerebral Tau Burden in Patients with Mild Cognitive Impairment due to Alzheimer's Disease: A Case Series

Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles

Regional associations of sleep architecture and Alzheimer's disease pathology